Stem Cell & Regenerative Eye Therapies

Future-Forward Treatment for Uncurable Eye Conditions at Erdem Hospital

Stem Cell and Regenerative Eye Therapies are an innovative and rapidly evolving field of medicine focused on repairing or replacing cells and tissues damaged by severe eye diseases. These advanced treatments offer hope for conditions that historically have had no cure, particularly degenerative, genetic, and chronic inflammatory disorders where functional cells have been lost, such as Retinitis Pigmentosa (RP) and severe Dry Age-Related Macular Degeneration (AMD).

At Erdem Hospital, we are closely following and, where ethically and scientifically sound, implementing regenerative approaches. We provide established reconstructive cell therapies like Limbal Stem Cell Transplantation (LSCT) for corneal disorders, while offering consultation and supportive treatment protocols for patients interested in promising, emerging therapies targeting the retina and optic nerve.

Turkey has become a recognized center for regenerative medicine, providing access to specialized cell processing and minimal-incision injection therapies for chronic eye conditions. International patients choose Erdem Hospital for expert guidance on these cutting-edge therapies, benefiting from high success rates in stabilization and significantly more affordable pricing.

Key Regenerative Applications in Ophthalmology

Regenerative therapies aim to harness the power of cells to stop disease progression, protect existing neurons, or, in the future, replace damaged cells.

Therapy Type	Procedure/Mechanism	Target Conditions	Primary Goal
Limbal Stem Cell Transplantation (LSCT)	Surgical transplantation of healthy limbal stem cells (often from the patient's other eye—autograft) to restore the cornea's regenerative surface.	Limbal Stem Cell Deficiency (LSCD), severe Chemical Burns, chronic scarring.	Restore a stable, transparent corneal surface.
Mesenchymal Stem Cell (MSC) Therapy	Intravitreal/Subtenon injection of stem cells (often umbilical cord-derived) to release neuroprotective and anti-inflammatory factors.	Retinitis Pigmentosa (RP), severe Dry AMD, Optic Atrophy, Glaucoma (supportive).	Slow the progression of degeneration and protect remaining vision.
Photobiomodulation (PBM) Therapy	Non-invasive treatment using specific low-dose light waves to increase energy (ATP) production in damaged retinal cells.	Dry AMD and other macular dystrophies.	Enhance cellular function, reduce inflammation, and slow vision loss.

Patient Suitability and Treatment Goals

Regenerative therapies require careful patient selection and are typically reserved for patients whose conditions have exhausted conventional treatments.

Ideal Candidates: Patients must generally have a stable eye structure (no severe shrinkage or deformity) and some residual vision. Individuals who are completely blind cannot benefit from these treatments. Early diagnosis is vital for success.
Primary Goal: The main purpose of most current regenerative therapies is to stop or significantly slow the progression of the degenerative disease.

What's Included in the Regenerative Therapy Journey

The service package is designed to be comprehensive and supportive, acknowledging the specialized nature of the treatment:

VIP airport-hotel-hospital transfers so you're never navigating on your own.
A three-night stay in premium accommodation.
Pre-treatment consultation and advanced diagnostic workup (Genetic Screening, OCT, Electrophysiology) to confirm suitability.
The Chosen Procedure (LSCT surgery, or MSC/PBM therapy session).
A full aftercare kit with required medications and drops (including long-term immunosuppressives for donor-source LSCT).
One year follow-up support to monitor the cell function and disease stability.
English-speaking staff and interpreters so nothing gets lost in translation.

Pricing and Affordability

Stem cell and regenerative eye therapies, while complex, are significantly more accessible in Turkey than in most countries.

Cost Savings: The average cost for stem cell therapy for eye diseases in Turkey often ranges from $4,000 to $15,000, which offers substantial savings compared to treatments in the US or Western Europe.
LSCT: Surgical cell transplantations like LSCT also remain highly cost-effective, providing critical care at a fraction of the international price.

Frequently Asked Questions (FAQ)

Are Stem Cell Therapies a cure for Retinitis Pigmentosa? Currently, they are not a cure but offer a protective strategy to slow the disease's progression.
What is the risk of rejection after LSCT? The risk is minimal if cells are taken from the patient's own healthy eye (autograft). Donor-source grafts require long-term immune suppression to manage rejection risk.
Does the treatment require general anesthesia? No, most therapies like MSC injections are minimally invasive, performed with only local anesthesia.
How is the treatment administered? Therapies are applied either surgically (LSCT) or via Intravitreal/Subtenon injection into the eye.
What is the difference between Gene Therapy and Stem Cell Therapy? Gene therapy targets a specific faulty gene, while stem cell therapy aims to replace or protect a wider range of damaged cells.

Restoring Confidence Through Hope and Innovation

Regenerative medicine offers a new horizon for preserving sight against complex diseases. At Erdem Hospital, we approach these advanced therapies with scientific rigor and ethical dedication. With 37 years of experience in patient care, we ensure patients are fully informed about the potential benefits and limitations of innovative treatments. Our goal is for you to feel looked after, supported, and confident in exploring every viable path to protect your vision.